Press Release

ATLANTA — Jan. 4, 2019 — In 2018, Bako Diagnostics (BakoDx) continued a long tradition of supporting the podiatric medical community. These efforts and commitments will continue in 2019. To view events for 2019, please click here. Watch this video recap of where BakoDx was present in 2018.

ATLANTA/BOSTON—October 10, 2018— Bako Diagnostics and StrataDx announce a strategic relationship. The parent company of Bako Diagnostics has acquired StrataDx, a leading U.S. dermatopathology and oral pathology laboratory, serving physicians across the U.S. While maintaining separate clinical laboratories, the common ownership allows the companies to operate more efficiently and bring their respective core services to broader markets, while continuing to serve their customers independently. “We are pleased to join with Bako Diagnostics in this strategic relationship,” stated Lisa Cohen, MD, CEO of StrataDx. “We will continue to provide our customers with the same high quality dermatopathology, oral pathology, surgical pathology [...]

ATLANTA — July 11, 2018 — Bako Diagnostics (BakoDx), the leader in nail dystrophy diagnostic testing, announced the availability of its expanded molecular test to include detection of the causative agent of green nail syndrome. Dr. Shari Lipner, assistant professor of dermatology at Weill Cornell Medicine, whose specialty is nail diseases, said she sees a lot of patients with onychomycosis along with another common problem — Pseudomonas aeruginosa — otherwise known as Green Nail Syndrome. “Pseudomonas nail infection is a very frustrating condition for patients because it’s often misdiagnosed,” Dr. Lipner said. “Having a molecular test to help with the [...]

ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced today that they have formed a Podiatric Advisory Board to assist in implementing the Company’s current plans and identifying means to capitalize on future growth opportunities. The board will provide guidance in navigating, innovating, and growing the organization to carry out its mission of providing the highest quality laboratory services and products customized for the podiatric medical profession. The Advisory Board, which is comprised of distinguished podiatrists, educators, innovators, and scholars, includes Allen M. Jacobs, DPM (St. Louis, MO), Jeffrey D. Lehrman, DPM (Springfield, PA) [...]

ATLANTA. Feb. 26, 2018 – Bako Diagnostics, a podiatry-focused clinical laboratory and products company, announced appointments to the Bako Clinical Consultant Team. This Team will represent Bako Diagnostics at various local, state, and national medical conferences, providing educational sessions and workshops. The Clinical Consultant Team, which is comprised of some of the most knowledgeable, accomplished, and dedicated podiatrists within the profession, includes: Javan S. Bass, DPM Lithonia, Georgia Robert M. Conenello, DPM Orangeburg, New York Andrew H. Cohen, DPM Saginaw, Michigan Brandon J. Hawkins, DPM Bakersfield, California LeRoy J. Kelley, III, DPM Norwood, Massachusetts Jeffrey D. Lehrman, DPM [...]

Company changes name to Bako Diagnostics and redesigns logo to reflect increased clinical laboratory services for podiatrists ATLANTA. Dec. 15 /PRNewswire/ - Bako, a podiatry-focused clinical laboratory and products company, announced today the launch of its new website-bakodx.com, new company name and newly designed company logo. As a partner and advocate to the podiatric community, the website is designed to be a leading source of education, innovation and insight for podiatrists. The company’s new name and new logo reflects the evolution of the company from Bako Integrated Physician Services to Bako Diagnostics. “We are excited to launch this new site [...]